Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer [Phase 3]
Phase 3 trial evaluating weekly docetaxel combined with CMF (cyclophosphamide, methotrexate, 5-fluorouracil) as adjuvant therapy for elderly…
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia [Phase 2]
Phase 2 clinical trial evaluating a granulocyte colony-stimulating factor therapy for safety and efficacy in patients at high risk of chemot…
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine and carboplatin with or without trastuzumab in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer [Phase 2]
This Phase 2 trial evaluated thalidomide in combination with capecitabine in patients with metastatic breast cancer. The study was terminate…
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating epirubicin and docetaxel for metastatic breast cancer has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer [Phase 1]
Phase I study evaluating ixabepilone plus lapatinib, with or without capecitabine, in HER2-positive breast cancer; the trial was terminated …
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating capecitabine, oxaliplatin, and trastuzumab for HER2-positive metastatic breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059) [Phase 4]
A phase 4 trial evaluating Caelyx (pegylated liposomal doxorubicin) as monotherapy in elderly patients with locally advanced or metastatic b…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer [Phase 3]
This entry reports on a Phase 3 trial investigating PET and MRI in the follow-up of patients who received neoadjuvant chemotherapy for breas…
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy [Phase 2]
A Phase II trial evaluating ertumaxomab for metastatic breast cancer after progression on trastuzumab was terminated. Results were posted in…
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluates trabectedin (ET-743) in patients with advanced breast cancer. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer [Phase 2]
Phase 2 trial update evaluating bevacizumab in combination chemotherapy for lymph node-positive breast cancer. The study included male breas…
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
The clinical trial evaluating lonafarnib in breast cancer has been terminated; the update does not provide results.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Predictive Genetic Risk Assessment Trial
This Mayo Clinic-sponsored trial on Predictive Genetic Risk Assessment has completed, investigating genetic risk prediction across multiple …
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients [Phase 2]
A Pfizer-sponsored Phase 2 trial evaluated exemestane as neoadjuvant therapy in operable breast cancer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen [Phase 3]
Phase 3 trial update evaluating exemestane as adjuvant therapy after five years of tamoxifen in postmenopausal women with resected Stage I-I…
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Herceptin and GM-CSF for Metastatic Breast Cancer [Phase 2]
This update reports the completion and posting of results for a Phase 2 trial of Herceptin (trastuzumab) with GM-CSF in metastatic breast ca…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer [Phase 2]
This Phase 2 trial compares two schedules of ixabepilone plus bevacizumab with paclitaxel plus bevacizumab in metastatic breast cancer, and …
-
CLINICAL_TRIALS trial_result · 2011-04-13Clinical Trial Update: Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer [Phase 2]
A Phase 2 trial evaluating arzoxifene or tamoxifen for breast cancer prevention in high-risk premenopausal women has completed. The study wa…
-
CLINICAL_TRIALS trial_result · 2011-04-13Clinical Trial Update: A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer
This clinical trial update reports on a pilot study evaluating the immunologic status of patients with HER2-positive breast cancer. The stud…
-
CLINICAL_TRIALS trial_result · 2011-04-12Clinical Trial Update: XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating XRP9881 in combination with trastuzumab for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-04Clinical Trial Update: Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer [Phase 2]
Phase 2 clinical trial comparing standard chemotherapy regimens with versus without ixabepilone (Ixempra) given before surgery in early-stag…
-
CLINICAL_TRIALS trial_result · 2011-04-04Clinical Trial Update: Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating trastuzumab, ixabepilone, and carboplatin in HER2-positive metastatic breast cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer [Phase 1]
Phase 1 trial evaluating trastuzumab with chemotherapy, followed by surgery and additional chemotherapy, in women with locally advanced brea…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer [Phase 1, Phase 2]
A clinical trial evaluating liposomal doxorubicin in combination with trastuzumab for women with advanced breast cancer has completed Phase …